Passage Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $5,912 |
Gross Profit | -800 | -806 | 5,105 | |
EBITDA | -15,148 | -16,143 | -17,244 | -17,639 |
EBIT | -15,907 | -16,940 | -18,050 | -18,446 |
Net Income | -19,340 | -15,991 | -16,710 | -16,758 |
Net Change In Cash | 0 | 0 | 0 | 5,912 |
Free Cash Flow | -7,467 | -13,136 | -18,929 | -19,529 |
Cash | 32,292 | 24,770 | 36,773 | 21,709 |
Basic Shares | 61,763 | 61,682 | 56,295 | 54,944 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,721 | -3,679 | -1,543 | -800 |
EBITDA | -98,341 | -138,394 | -185,729 | -112,902 |
EBIT | -102,062 | -142,073 | -187,272 | -113,702 |
Net Income | -102,062 | -136,856 | -191,500 | -111,762 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -94,364 | -6,037 | -23,872 | |
Free Cash Flow | -78,410 | -123,484 | -152,521 | -82,166 |
Cash | 21,709 | 34,601 | 128,965 | 135,002 |
Basic Shares | 54,743 | 54,429 | 53,343 | 38,615 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.23 |
2024-06-30 | -$0.26 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.30 |
